By Seres Therapeutics | November 16, 2017Novel Collaboration Will Support Investigation of Microbiome Therapeutics for Immuno-Oncology
By Seres Therapeutics | October 5, 2017Seres Therapeutics Reports Positive Topline Results from SER-287 Phase Ib UC Study